Hydroxyurea remains effective long-term in reducing emergency department visits and hospital days for children living with sickle cell disease (SCD), according to new research published in Blood ...

Today, CASGEVY is approved for use in patients with sickle cell disease in the United States and multiple countries in Europe and the Middle East. “It’s an amazing gift to have been able to ...

THIS DRIVE AT DARTMOUTH COLLEGE IS AN EFFORT TO HELP PEOPLE SUFFERING FROM THE MOST COMMON GENETIC BLOOD DISORDER IN THE U.S., SICKLE CELL DISEASE. IT CAN CAUSE CHRONIC PAIN AND OTHER SERIOUS ...

THIS DRIVE AT DARTMOUTH COLLEGE IS AN EFFORT TO HELP PEOPLE SUFFERING FROM THE MOST COMMON GENETIC BLOOD DISORDER IN THE U.S., SICKLE CELL DISEASE. IT CAN CAUSE CHRONIC PAIN AND OTHER SERIOUS ...

Sickle cell disease is an autosomal recessive blood disorder that can lead to anaemia. It is caused by a mutation in the haemoglobin gene, which leads to deformation of red blood cells.

She also tackled another major misconception: that sickle cell is only a “Black disease,“ explaining its global ties and high numbers, especially in Nigeria and India. With new international ...

A study of U.S. children with sickle cell disease found fewer than half get a needed screening for stroke, a common complication. Pfizer is buying sickle cell drug maker Global Blood Therapeutics ...